推薦產品
產品名稱
Discovery® HS C18 高效液相色谱柱, 3 μm particle size, L × I.D. 7.5 cm × 4.6 mm
材料
stainless steel column
品質等級
agency
suitable for USP L1
產品線
Discovery®
特點
endcapped
製造商／商標名
Discovery®
包裝
1 ea of
標籤範圍
20% Carbon loading
參數
≤70 °C temp. range
400 bar pressure (5801 psi)
技術
HPLC: suitable
LC/MS: suitable
長度 × 內徑
7.5 cm × 4.6 mm
表面積
300 m2/g
表面覆盖率
3.2 μmol/m2
雜質
<10 ppm metals
基質
silica gel, high purity, spherical particle platform
fully porous particle
基質活性組
C18 (octadecyl) phase
粒徑
3 μm
孔徑
120 Å
工作pH值範圍
2-8
應用
food and beverages
分離技術
reversed phase
尋找類似的產品？ 前往 產品比較指南
一般說明
Discovery® HS C18 HPLC柱（L × 内径7.5 cm × 4.6 mm）在酸性和碱性条件下一般比较稳定。
應用
- 一种稳定性指示RP-HPLC方法，用于渗透性研究中以纳米制剂应用的COVID-19药物莫努匹韦的测定。：本研究展示了使用Discovery® HS C18 HPLC色谱柱开发分析莫努匹韦的稳健HPLC方法，展示了其在当前疫情相关药物研究中的重要性（Recber et al., 2022）。
- 一种新的RP-HPLC方法，作为优化样品制备程序的辅助工具，用于追踪不同亲水性PPCP。：重点介绍了Discovery® HS C18 HPLC色谱柱在环境监测中的适用性，特别是在制药和个人护理产品方面，改善了环境安全分析方法（Portillo-Castillo et al., 2021）。
- HPLC-UV法分析血浆中的特立齐酮及其在耐药结核病患者药代动力学研究中的应用。：本研究使用Discovery® HS C18 HPLC色谱柱评估患者血浆中的特立齐酮水平，为耐药结核病的治疗提供重要见解（Mulubwa and Mugabo, 2018）。
- 从药代动力学、生物医学和药物监测治疗研究的角度优化定量检测血浆和尿液样品中阿霉素的LC方法。：介绍了使用Discovery® HS C18 HPLC色谱柱优化强效化疗药物阿霉素的液相色谱检测方法，强调了其在治疗药物监测中的作用（Maliszewska et al., 2018）。
- 通用HPLC-UV法测定转运研究、大鼠胎盘灌注和胎盘裂解物中的依非韦伦。：展示了Discovery® HS C18 HPLC色谱柱在研究依非韦伦在胎盘中的渗透性和转运方面的应用，提供了有价值的药理学见解（Zelena et al., 2017）。
特點和優勢
- 稳定性好、低流失，适用于 LC-MS 分析
- 提供有适用于分析型到制备型的各种规格
- 稳定性好，以确保柱与柱和批与批之间之间优良的重现性
- 更强的疏水性能够更好地分离难分析化合物
法律資訊
Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Jolanta Flieger et al.
Journal of separation science, 34(7), 733-739 (2011-03-02)
Highly hydrophilic compounds belonging to biogenic amines were analysed in the reversed-phase system, modified with the addition of ionic liquids: 1-ethyl-3-methyl-imidazolium hexafluorophosphate (EMIM PF(6)) and chaotropic salt NaPF(6) on Discovery HS C18 column at acidic conditions. The effect of the
Swati Jaiswal et al.
Journal of chromatographic science, 55(6), 617-624 (2017-03-24)
Tuberculosis (TB) with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome represents the most common infectious diseases worldwide. Anti-TB drugs are used concurrently with antiretroviral drug for treatment of TB-HIV co-morbidities. Due to lower risk of interaction with protease inhibitors, rifabutin is
Abad Khan et al.
Talanta, 84(3), 789-801 (2011-04-13)
A new, simple, economical and validated high-performance liquid chromatography linked with electrochemical detector (HPLC-ECD) method has been developed and optimized for different experimental parameters to analyze the most common monothiols and disulfide (cystine, cysteine, homocysteine, methionine, reduced (GSH) and oxidized
Bhavin N Patel et al.
Biomedical chromatography : BMC, 22(11), 1213-1224 (2008-07-25)
A simple, precise and accurate assay for the determination of 6-methoxy-2-naphthylacetic acid (6-MNA), an active metabolite of nabumetone in human plasma, was developed and validated using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The analyte (6-MNA) and propranolol (internal standard, IS) were
Abad Khan et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(28), 2782-2788 (2010-09-11)
A rapid, inexpensive, sensitive and specific HPLC-ECD method for the determination of lipoic acid in human plasma was developed and validated over the linearity range of 0.001-10μg/ml using naproxen sodium as an internal standard (IS). Extraction of lipoic acid and
相關內容
HPLC DiscoveryBIO HS C18 products. Available in 3µm, 5µm and 10µm particle sizes.
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務